Innovations in Oncology 2019
-
s Sponsored
How risk-adapted radiotherapy is revolutionising breast cancer care
Personalised treatment for breast cancer has made therapies more targeted and patients’ lives easier. The next big breakthroughs could be here before long, says one cancer specialist. “This is an exciting time to be working in the field of breast cancer,” says Dr Imogen Locke, Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust....
-
Improving survival in bowel cancer patients
Bowel cancer is the fourth most common cancer in the UK, with 42,000 cases diagnosed per year. It is treatable and curable if diagnosed early, but only 10-15% present early enough. The five year survival for colon and rectal cancer remains at 65% and 67% respectively. Over 20% of cases present very late with locally...
-
I couldn’t have imagined the successes we are seeing from immunotherapy
Scientists are further exploring checkpoint inhibitors and cell therapies as ways to use immunotherapy more widely in the fight against cancer. The way we treat cancer has progressed over recent years and immunotherapy has had a big impact in allowing patients’ immune systems to uncover and attack cancers that may have previously gone undetected. When...
-
Could exercise beat advanced prostate cancer?
Regular workouts can help men with early prostate cancer live better, for longer but could it also help patients with advanced disease? Staying physically active might be the last thing on your mind when you’re exhausted from dealing with cancer – but exercise make a huge difference before, during and after treatment. Continuing to be...
-
A late stage killer: why early diagnosis is so important
The NHS’ Long Term Plan places cancer at the heart of its agenda. Local systems have been given ambitious targets to improve screening, diagnosis and survival rates and their forthcoming operational plans must demonstrate how they will achieve this. Two key targets in the Long Term Plan are: by 2028, the proportion of cancers diagnosed...
-
Artificial intelligence – great potential to reduce inefficiencies, errors and cost
Cancer detection in women may be more efficient and affordable with the use of artificial intelligence. However, more research is needed to address its real-world applicability and safety. Cancer early detection requires examination by a trained health provider using different imaging techniques, endoscopic examinations and pathological investigations. Irrespective of the methodology, the detection of diseases...
-
Translating research into life-saving outcomes for patients
Harnessing the immune system to treat cancer has seen much success, but challenges remain. How can we create the right environment to maximise its life-saving potential for patients? Immunology has flourished in recent years, with new discoveries allowing us to understand its extensive involvement in maintaining health and the consequences that occur when these processes...
-
s Sponsored
Data-driven medicine is in the House: Cancer becomes personal
House M.D. is my guilty pleasure – it’s hard not to love watching a good medical mystery solved by grouchy genius Dr Gregory House approaching diseases like a detective. Now consider the show from a patient’s point of view; imagine the pain, anxiety, and uncertainty they experience when faced with the disease, under the care...
-
Why the way forward in oncology is data-driven
A data-driven approach to healthcare has the potential to speed up diagnosis and guide more effective, personalised treatments. It could have huge benefits in the field of oncology. Some cancers can be difficult to detect, largely because symptoms are not always obvious in their early stages. “Many cancers that arise in deep-seated organs — such...
Health Awareness
